1. Moxifloxacin and biofilm production by coagulase-negative staphylococci.
- Author
-
Pérez-Giraldo C, Gonzalez-Velasco C, Sánchez-Silos RM, Hurtado C, Blanco MT, and Gómez-García AC
- Subjects
- Biofilms growth & development, Coagulase metabolism, Fluoroquinolones, Microbial Sensitivity Tests, Moxifloxacin, Staphylococcus epidermidis isolation & purification, Staphylococcus epidermidis physiology, Anti-Bacterial Agents pharmacology, Aza Compounds pharmacology, Biofilms drug effects, Quinolines pharmacology, Staphylococcus epidermidis drug effects
- Abstract
The in vitro activity of moxifloxacin against 41 strains of coagulase-negative staphylococci was determined. A relationship between the activity of moxifloxacin and biofilm formation was detected. Biofilm-producing strains were more resistant to moxifloxacin than biofilm-negative strains. Our global results obtained with six strains of Staphylococcus epidermidis showed that subinhibitory concentrations of moxifloxacin did not significantly modify biofilm formation. On the other hand, moxifloxacin concentrations of 2, 10, 50 and 100 x MIC produced a log decrease in viable count (included in a biofilm) of 0.20, 0.37, 1.10 and 1.69, respectively., (Copyright 2004 S. Karger AG, Basel)
- Published
- 2004
- Full Text
- View/download PDF